-+ 0.00%
-+ 0.00%
-+ 0.00%

ACLARIS THERAPEUTICS INITIATES PHASE 2B TRIAL OF MODZATINIB (ATI-2138) IN LICHEN PLANUS (LP)

Reuters·11/16/2026 08:30:00

Please log in to view news